Kyung-Hwa Jung1, Hei-Lim Choi2, Soojin Park3, Geunhyeog Lee4, Miran Kim5, Joon-Ki Min6, Byung-Il Min7, Hyunsu Bae8. 1. Department of Physiology, College of Korean Medicine, Kyung Hee University, #1 Hoekidong, Dongdaemoon-ku, Seoul 130-701, Republic of Korea. Electronic address: jhkh242@naver.com. 2. Department of East-West Medicine, Kyung Hee University, #1 Hoekidong, Dongdaemoon-ku, Seoul 130-701, Republic of Korea. Electronic address: estella277@hanmail.net. 3. Department of Physiology, College of Korean Medicine, Kyung Hee University, #1 Hoekidong, Dongdaemoon-ku, Seoul 130-701, Republic of Korea. Electronic address: ih_sj@naver.com. 4. Central Research Institute, Hanlim Pharm. Co. Ltd., 1007 Yoobang Dong, Yongin, Kyounggi Do, Republic of Korea. Electronic address: duddms0910@naver.com. 5. Central Research Institute, Hanlim Pharm. Co. Ltd., 1007 Yoobang Dong, Yongin, Kyounggi Do, Republic of Korea. Electronic address: kmr@hanlim.com. 6. Department of East-West Medicine, Kyung Hee University, #1 Hoekidong, Dongdaemoon-ku, Seoul 130-701, Republic of Korea. Electronic address: drminjk@naver.com. 7. Department of East-West Medicine, Kyung Hee University, #1 Hoekidong, Dongdaemoon-ku, Seoul 130-701, Republic of Korea. Electronic address: mbi@khu.ac.kr. 8. Department of Physiology, College of Korean Medicine, Kyung Hee University, #1 Hoekidong, Dongdaemoon-ku, Seoul 130-701, Republic of Korea; Institute of Korean Medicine, Kyung Hee University, #1 Hoekidong, Dongdaemoon-ku, Seoul 130-701, Republic of Korea. Electronic address: hbae@khu.ac.kr.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: PM014 is a modified form of the Chung-Sang-Bo-Ha-Tang (CSBHT) herbal formula that has been used to treat chronic pulmonary diseases in Korea for centuries. Previously, we developed a formulation of PM014 based on a series of in vitro and in vivo screening efforts that comprises seven herbal extracts. The PM014 formula includes the root of Rehmannia glutinosa, the cortex of Paeonia suffruticosa, the fruit of Schizandra chinensis, the root of Asparagus cochinchinensis, seeds of Prunus armeniaca, the root of Scutellaria baicalensis and the root of Stemona sessilifolia. Asthma is a chronic inflammatory disease of the lungs that is characterized by wheezing, bronchial contraction, and chest tightness. In addition, the airway becomes hypersensitive and narrows through an inflammatory reaction mediated by Th2 cells. The present study was conducted to evaluate the ability of PM014 to prevent allergic airway inflammation and to attenuate airway responses in a cockroach allergen-induced mouse model. MATERIALS AND METHODS: Mice sensitized to and challenged with cockroach allergen were treated with oral administration of PM014. Airway resistance was determined by whole body plethysmography. In addition, Th2 cytokines and immune cell profiles of bronchoalveolar lavage (BAL) fluid and inflammatory mediators in serum were analyzed by ELISA. A series of histological examinations were also conducted to demonstrate the effects of PM014 on airway remodeling, goblet cell hyperplasia and inflammatory responses in the lung. RESULTS: PM014 significantly inhibited the number of total cells, eosinophils, neutrophils, macrophages and lymphocytes in the BAL fluid of mice that were challenged with cockroach allergen. In addition, PM014 reduced the levels of Th2 cytokines (IL-4, IL-5 and IL-13) in the BAL fluid and inflammatory mediators such as IgE in the serum, as measured by enzyme-linked immunosorbent assay (ELISA). Histopathological analysis also showed that PM014 substantially inhibited eosinophil infiltration into the airway, goblet cell hyperplasia and smooth muscle hypertrophy. CONCLUSIONS: In this study, our results indicate that PM014 has significant effects on allergic airway inflammation upon exposure to cockroach allergen in a mouse model. According to these outcomes, PM014 may have therapeutic potential as a treatment for allergic asthma.
ETHNOPHARMACOLOGICAL RELEVANCE: PM014 is a modified form of the Chung-Sang-Bo-Ha-Tang (CSBHT) herbal formula that has been used to treat chronic pulmonary diseases in Korea for centuries. Previously, we developed a formulation of PM014 based on a series of in vitro and in vivo screening efforts that comprises seven herbal extracts. The PM014 formula includes the root of Rehmannia glutinosa, the cortex of Paeonia suffruticosa, the fruit of Schizandra chinensis, the root of Asparagus cochinchinensis, seeds of Prunus armeniaca, the root of Scutellaria baicalensis and the root of Stemona sessilifolia. Asthma is a chronic inflammatory disease of the lungs that is characterized by wheezing, bronchial contraction, and chest tightness. In addition, the airway becomes hypersensitive and narrows through an inflammatory reaction mediated by Th2 cells. The present study was conducted to evaluate the ability of PM014 to prevent allergic airway inflammation and to attenuate airway responses in a cockroach allergen-induced mouse model. MATERIALS AND METHODS:Mice sensitized to and challenged with cockroach allergen were treated with oral administration of PM014. Airway resistance was determined by whole body plethysmography. In addition, Th2 cytokines and immune cell profiles of bronchoalveolar lavage (BAL) fluid and inflammatory mediators in serum were analyzed by ELISA. A series of histological examinations were also conducted to demonstrate the effects of PM014 on airway remodeling, goblet cell hyperplasia and inflammatory responses in the lung. RESULTS:PM014 significantly inhibited the number of total cells, eosinophils, neutrophils, macrophages and lymphocytes in the BAL fluid of mice that were challenged with cockroach allergen. In addition, PM014 reduced the levels of Th2 cytokines (IL-4, IL-5 and IL-13) in the BAL fluid and inflammatory mediators such as IgE in the serum, as measured by enzyme-linked immunosorbent assay (ELISA). Histopathological analysis also showed that PM014 substantially inhibited eosinophil infiltration into the airway, goblet cell hyperplasia and smooth muscle hypertrophy. CONCLUSIONS: In this study, our results indicate that PM014 has significant effects on allergic airway inflammation upon exposure to cockroach allergen in a mouse model. According to these outcomes, PM014 may have therapeutic potential as a treatment for allergic asthma.
Authors: Ju Hee Lee; Hun Jai Lim; Chan Woo Lee; Kun-Ho Son; Jong-Keun Son; Sang Kook Lee; Hyun Pyo Kim Journal: Evid Based Complement Alternat Med Date: 2015-08-25 Impact factor: 2.629
Authors: Hyun Ah Lee; Bo Ram Song; Hye Ryeong Kim; Ji Eun Kim; Woo Bin Yun; Jin Ju Park; Mi Lim Lee; Jun Young Choi; Hee Seob Lee; Dae Youn Hwang Journal: Exp Ther Med Date: 2017-09-25 Impact factor: 2.447
Authors: Jun Young Choi; Ji Won Park; Ji Eun Kim; Jin Ju Park; Mi Rim Lee; Bo Ram Song; Mi Ju Kang; Dae Youn Hwang Journal: Lab Anim Res Date: 2018-09-27
Authors: Jun Young Choi; Ji Eun Kim; Jin Ju Park; Mi Rim Lee; Bo Ram Song; Ji Won Park; Mi Ju Kang; Hee Seob Lee; Hong Joo Son; Jin Tae Hong; Dae Youn Hwang Journal: J Clin Med Date: 2018-10-22 Impact factor: 4.241